PerkinElmer Inc (NYSE:PKI)

51.09
Delayed Data
As of Mar 27
 +0.58 / +1.15%
Today’s Change
38.96
Today|||52-Week Range
51.18
+16.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$5.8B

Company Description

PerkinElmer, Inc. (United States) engages in the provision of products and solutions to diagnostics, research, and laboratory services. it operates through the Human Health and Environmental Health segments. The Human Health segment researches and develops therapies such as genetic disorder detections, screening products, infectious disease testing, drug discoveries. The Environmental Health segment produces and sells products and solutions which include harmful substances detection in food, water, and surroundings. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Contact Information

PerkinElmer, Inc. (United States)
940 Winter Street
Waltham Massachusetts 02451
P:(781) 663-6900
Investor Relations:
(781) 663-5889

Employees

Shareholders

Mutual fund holders60.93%
Other institutional33.02%
Individual stakeholders2.16%

Top Executives

Robert F. FrielChairman, President & Chief Executive Officer
Frank Anders WilsonCFO, SVP & Principal Financial Officer
Joel S. GoldbergSecretary, SVP-Administration & General Counsel
Jonathan DiVincenzoPresident-Environmental Health & Senior VP
Andrew OkunCAO, Vice President & Principal Accounting Officer

To view my watchlist

Not a member yet?

Sign up now for a free account